[Renfu Pharmaceutical: gabapentin capsule obtains Drug Registration Certificate] May 31, Renfu Pharmaceutical announcement, the holding subsidiary Wuhan Renfu Pharmaceutical Co., Ltd. (referred to as "Wuhan Renfu") recently received the "Drug Registration Certificate" of gabapentin capsule approved and issued by the State Drug Administration. Gabapentin capsule is used in the treatment of post-herpetic neuralgia and adjuvant treatment of partial seizures.